Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NasdaqCM - Nasdaq Real Time Price USD

IceCure Medical Ltd (ICCM)

Compare
1.2300
-0.0100
(-0.81%)
At close: April 3 at 4:00:00 PM EDT
1.2400
0.00
(0.00%)
Pre-Market: 5:27:20 AM EDT
All All Favorites Text Statistics Technicals Fibonacci Markings Lines
Loading Chart for ICCM

Recent News: ICCM

View More
IceCure Medical Stock Dips Despite Positive ICESECRET Study Results

IceCure Medical Stock Dips Despite Positive ICESECRET Study Results
Zacks 6 days ago
IceCure Medical Full Year 2024 Earnings: Misses Expectations

IceCure Medical Full Year 2024 Earnings: Misses Expectations
Simply Wall St. 6 days ago
IceCure Medical Reports 2024 Financial Results: 42% Growth in ProSense® Cryoablation Sales in North America

IceCure Medical Reports 2024 Financial Results: 42% Growth in ProSense® Cryoablation Sales in North America
PR Newswire 7 days ago
IceCure's ICESECRET Kidney Cancer Cryoablation Study Interim Results Presented at European Association of Urology Conference in Spain: 88.7% Recurrence-Free Rate

IceCure's ICESECRET Kidney Cancer Cryoablation Study Interim Results Presented at European Association of Urology Conference in Spain: 88.7% Recurrence-Free Rate
PR Newswire 10 days ago
IceCure Medical to Report 2024 Full Year Financial & Operational Results on March 27, 2025

IceCure Medical to Report 2024 Full Year Financial & Operational Results on March 27, 2025
PR Newswire 13 days ago
IceCure Reports Updated Timeline and Progress with FDA Regarding Marketing Authorization for ProSense® Cryoablation in Early-Stage Breast Cancer

IceCure Reports Updated Timeline and Progress with FDA Regarding Marketing Authorization for ProSense® Cryoablation in Early-Stage Breast Cancer
PR Newswire 14 days ago
IceCure's ProSense® Cryoablation Featured in Six Studies Presented at St. Gallen International Breast Cancer Conference

IceCure's ProSense® Cryoablation Featured in Six Studies Presented at St. Gallen International Breast Cancer Conference
PR Newswire 16 days ago
IceCure Receives Notice of Allowance in China for Novel Cryogenic Pump for Next-Generation Cryoablation Technology

IceCure Receives Notice of Allowance in China for Novel Cryogenic Pump for Next-Generation Cryoablation Technology
PR Newswire 17 days ago
Breast Cancer Patients who Underwent IceCure's ProSense® Cryoablation in Japan Reported Significantly Higher Satisfaction than Patients who Underwent Standard of Care Surgery

Breast Cancer Patients who Underwent IceCure's ProSense® Cryoablation in Japan Reported Significantly Higher Satisfaction than Patients who Underwent Standard of Care Surgery
PR Newswire 24 days ago
IceCure seeks Israeli regulatory approval for XSense cryoablation system

IceCure seeks Israeli regulatory approval for XSense cryoablation system
Medical Device Network last month
IceCure Submits Filing for Regulatory Approval of its Next-Generation XSense™ Cryoablation System in Israel

IceCure Submits Filing for Regulatory Approval of its Next-Generation XSense™ Cryoablation System in Israel
PR Newswire last month
View More

Related Tickers

BWAY BrainsWay Ltd.
9.08
-4.32%
 
XYLO Xylo Technologies Ltd.
5.28
+5.56%
 
MASI Masimo Corporation
152.37
-11.14%
 
TNON Tenon Medical, Inc.
1.3300
-9.52%
 
XAIR Beyond Air, Inc.
0.2454
-2.35%
 
VVOS Vivos Therapeutics, Inc.
2.5700
0.00%
 
ALUR Allurion Technologies Inc.
3.1200
-6.87%
 
AEMD Aethlon Medical, Inc.
0.3493
-4.54%
 
TIVC Tivic Health Systems, Inc.
4.8700
+49.85%
 
NAOV NanoVibronix, Inc.
2.3200
-9.38%